Back to Search Start Over

Primary and secondary intralymphatic histiocytosis.

Authors :
Bakr, Farrah
Webber, Naomi
Fassihi, Hiva
Swale, Victoria
Lewis, Fiona
Rytina, Ed
Ben-Zvi, Galia Tamar
Norris, Paul
Espinosa, Olivia
Dhar, Sunanda
Craig, Paul
Robson, Alistair
Source :
Journal of the American Academy of Dermatology; May2014, Vol. 70 Issue 5, p927-933, 7p
Publication Year :
2014

Abstract

Background: Intralymphatic histiocytosis (IH) is a rare condition often associated with systemic disease. A benign condition, clinical presentations can vary greatly and its cause is largely unknown. Histologically, there are macrophages within distended lymphatic vessels, although this can be an incidental finding or the primary abnormality. Objective: We present a series of 7 cases of IH with and without disease associations, and a review of the literature. We propose IH as either primary (without associated conditions) or secondary (associated with systemic disease). Methods: This was a retrospective collection of patients whose skin biopsy specimens revealed intralymphatic collections of histiocytes. We reviewed their clinical presentation, disease associations, and staining of slides with CD68 in all cases, D2-40 in 5 cases, and HLA-DR in 4 cases. Results: Clinical features were highly variable, and not all cases were associated with systemic disease. One case had admixed reactive angioendotheliomatosis. All 4 cases stained for HLA-DR showed strong expression by the intralymphatic macrophages. Limitations: Retrospective analysis and limited numbers are limitations. Conclusion: IH is not always associated with systemic disease although macrophage activation nevertheless implies immune activation. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
01909622
Volume :
70
Issue :
5
Database :
Supplemental Index
Journal :
Journal of the American Academy of Dermatology
Publication Type :
Academic Journal
Accession number :
95582996
Full Text :
https://doi.org/10.1016/j.jaad.2013.11.024